ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post-Operative Osteosarcoma Treatment.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High-performance hydrogels in orthopedics: Structural design, performance tuning, and clinical potential.Materials today. Bio · 2026Review
- Bifunctional scaffolds: strategic bridges coordinating osteosarcoma therapy and bone regeneration.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Surgery is a mainstream treatment of osteosarcoma in the clinic, which often causes critical-size bone defects due to its highly invasive nature. However, the post-operative osteosarcoma management still remains challenging, characterized by high risks of recurrence and insufficient defect recovery. Recent studies increasingly reveal that the osteoimmune system is a crucial mediator of bone homeostasis and immune protection functions, emerging as a crucial nexus linking the antitumor immunity and osteopromotion regimes. Consequently, there is significant interest to develop new strategies to modulate the immune responses in the post-operative defect site, aiming to sustainably inhibit residual tumor growth and recurrence while accelerating defect regeneration. Interestingly, orthopedic implants emerge as optimal platforms for the on-demand engineering of immune responses in the post-operative defects in a highly integrative approach. Herein, a comprehensive review is provided on the principles and designs of osteoimmunomodulatory orthopedic implants for evoking osteosarcoma-specific immunity while boosting osseointegration and bone defect recovery. Overall, osteoimmunomodulatory orthopedic implants offer immense potential for ameliorating the osteosarcoma treatment outcome by improving patient survival and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.